These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7051951)

  • 1. [Cellular receptors for complement components: repertory and functions].
    Sobel A; Blanc C; Cattaneo A; Moisy M; Lopez-Trascasa M
    Ann Immunol (Paris); 1982; 133C(2):199-205. PubMed ID: 7051951
    [No Abstract]   [Full Text] [Related]  

  • 2. Complement ligand-receptor interactions that mediate biological responses.
    Fearon DT; Wong WW
    Annu Rev Immunol; 1983; 1():243-71. PubMed ID: 6242465
    [No Abstract]   [Full Text] [Related]  

  • 3. Complement activation and C1q binding activity in haemodialysis.
    Dodd NJ; Vergani D; Turney JH; Parsons V; Weston MJ
    Proc Eur Dial Transplant Assoc; 1981; 18():300-4. PubMed ID: 6977138
    [No Abstract]   [Full Text] [Related]  

  • 4. [Correlations between complement degradation products and circulating immune complexes in human glomerulonephritis].
    Coppo R; De Marchi M; Alloatti S; Segoloni G; Giacchino F; Quarello F; Roccatello D; Bulzomi MR; Piccoli G
    Minerva Nefrol; 1979; 26(3):243-50. PubMed ID: 318057
    [No Abstract]   [Full Text] [Related]  

  • 5. C1q acts synergistically with phorbol dibutyrate to activate CR1-mediated phagocytosis by human mononuclear phagocytes.
    Bobak DA; Frank MM; Tenner AJ
    Eur J Immunol; 1988 Dec; 18(12):2001-7. PubMed ID: 2975599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biochemistry of complement.
    Porter RR; Reid KB
    Nature; 1978 Oct; 275(5682):699-704. PubMed ID: 703835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and function of membrane complement receptors. Summary.
    Ross GD
    Fed Proc; 1982 Dec; 41(14):3089-93. PubMed ID: 6982833
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum complement components in patients with trachoma.
    Sen DK; Sarin GS; Hiranandani M; Baveja UK
    Br J Ophthalmol; 1985 Sep; 69(9):707-10. PubMed ID: 3876110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The classical complement pathway: mechanism of activation of the first component by antigen-antibody complexes.
    Loos M
    Prog Allergy; 1982; 30():135-92. PubMed ID: 7041131
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoglobulin-independent utilization of the classical complement pathway in opsonophagocytosis of Escherichia coli by human peripheral leukocytes.
    Leist-Welsh P; Bjornson AB
    J Immunol; 1982 Jun; 128(6):2643-51. PubMed ID: 6210733
    [No Abstract]   [Full Text] [Related]  

  • 11. The complement system: physiology, disorders, and activity in the newborn infant.
    Johnston RB
    Mead Johnson Symp Perinat Dev Med; 1986; (24):7-12. PubMed ID: 2943950
    [No Abstract]   [Full Text] [Related]  

  • 12. Complement deposition in glomerular diseases.
    di Belgiojoso GB; Tarantino A; Durante A; Guerra L
    Proc Eur Dial Transplant Assoc; 1975; 11():515-21. PubMed ID: 1105561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complement system.
    Boackle RJ
    Immunol Ser; 1990; 50():143-71. PubMed ID: 2091755
    [No Abstract]   [Full Text] [Related]  

  • 14. Circulating immune complexes in patients with glomerulonephritis and in renal transplant patients.
    Sølling J
    Scand J Urol Nephrol Suppl; 1985; 97():1-46. PubMed ID: 3915401
    [No Abstract]   [Full Text] [Related]  

  • 15. Complement activation by immunoglobulin does not depend solely on C1q binding.
    Bindon CI; Hale G; Waldmann H
    Eur J Immunol; 1990 Feb; 20(2):277-81. PubMed ID: 2311645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane attack complex of complement as a pathologic mediator.
    Biesecker G
    Lab Invest; 1983 Sep; 49(3):237-49. PubMed ID: 6193330
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune complexes in diabetes mellitus: studies of complement utilisation and tissue deposition.
    Charlesworth JA; Campbell LV; Catanzaro R; Pussell BA; Pasterfield GV; Peake P
    J Clin Lab Immunol; 1982 Sep; 8(3):163-8. PubMed ID: 6752415
    [No Abstract]   [Full Text] [Related]  

  • 18. [Complement activation and biological activities].
    Inoue K
    Nihon Saikingaku Zasshi; 1976 Jul; 31(4):535-55. PubMed ID: 988219
    [No Abstract]   [Full Text] [Related]  

  • 19. Modification of glomerular immune complex deposits.
    McCluskey RT
    Lab Invest; 1983 Mar; 48(3):241-4. PubMed ID: 6219247
    [No Abstract]   [Full Text] [Related]  

  • 20. Glomerular lesions induced by interferon.
    Morel-Maroger L
    Transplant Proc; 1982 Sep; 14(3):499-505. PubMed ID: 6217602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.